Hutch News

Hutch News

Stories tagged 'Adaptive Biotechnologies'

Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy

Immune-based treatments move from the fringes to the spotlight

June 16, 2017 | By Susan Keown / Fred Hutch News Service

What's new in cancer immunotherapy? Five hot topics, from new combination therapies to cost.

View story >


How research and industry partnerships can advance cancer care

Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care

Sept. 27, 2016 | By Rachel Tompa / Fred Hutch News Service

Inaugural 'Oncology Summit,' co-hosted by Fred Hutch and Merck, allowed investors, key players in life sciences to collaborate and share scientific stories.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 3, 2016

Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 15, 2015 | By Fred Hutch News Service staff

Dr. Leo Stamatatos gets funding to manufacture, test first Hutch-developed HIV vaccine candidate; Dr. Lu Chen authors largest study yet to examine breast cancer disparities; Dr. Amit Sharma wins Foundation for AIDS Research (amfAR) award; Dr. Harlan Robins of Adaptive Technologies among ‘100 Most Intriguing Entrepreneurs’

View story >


Why cancer research needs business development – now more than ever

Meet Fred Hutch’s Dr. Niki Robinson, the woman who’s helping make it happen

July 24, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Nonprofit cancer research centers like the Hutch need business partnerships to get discoveries into the clinic faster. Meet the new VP who's helping make it happen.

View story >


Study may lead to development of new diagnostic tools for ovarian cancer

Research co-led by Harlan Robins and Adaptive Biotechnologies reveals an even distribution of immune fighter T cells in ovarian tumors

Oct. 15, 2013

A study co-led by Fred Hutchinson Cancer Research Center and Adaptive Biotechnologies Corporation, published online ahead of print in the Journal of Pathology, has found that ovarian tumors contain an even distribution of immune fighter T cells, despite the fact that the cancer genome itself is diverse.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.